抗癫痫药物使用与痴呆风险:芬兰健康登记与德国医保数据分析
基于芬兰公共卫生登记和德国医保数据的病例对照分析,纳入德国各类痴呆患者20325例和芬兰阿尔茨海默病(AD)患者70718例,匹配无痴呆对照。定期使用抗癫痫药物(AED)与痴呆风险升高相关(调整OR=1.28,95%CI=1.14-1.44),与AD风险升高相关(调整OR=1.15,95%CI=1.09-1.22);具有已知认知不良反应(CAE)的AED风险更高。
要点
- 定期使用AED与痴呆风险升高相关(调整OR=1.28)。
- 定期使用AED与AD风险升高相关(调整OR=1.15)。
- 具有已知CAE的AED与更高痴呆风险相关(OR=1.59)。
核心结论
- AED尤其是具有已知认知不良反应的药物,可能促进老年人发生痴呆和AD。
研究设计与样本
- 病例对照分析,数据来自芬兰公共卫生登记和德国医保数据。
- 德国数据纳入各类痴呆患者20325例,芬兰数据纳入AD患者70718例,匹配至多4名无痴呆对照。
- 引入2年滞后时间以处理潜在前驱偏倚,采用条件logistic回归计算OR并调整共病和多药等混杂因素。
主要发现
- 痴呆患者中定期使用AED的比例高于对照。
- 定期使用AED者痴呆风险显著高于未使用者(调整OR=1.28,95%CI=1.14-1.44)。
- 定期使用AED者AD风险显著高于未使用者(调整OR=1.15,95%CI=1.09-1.22)。
- 观察到暴露越高痴呆风险越高的趋势。
- 具有已知CAE的AED与痴呆风险显著升高相关(OR=1.59,95%CI=1.36-1.86),与AD风险升高相关(OR=1.19,95%CI=1.11-1.27)。
关键数值与推荐
- 定期使用AED与痴呆风险的调整OR=1.28(95%CI=1.14-1.44)。
- 定期使用AED与AD风险的调整OR=1.15(95%CI=1.09-1.22)。
- 具有已知CAE的AED与痴呆风险的OR=1.59(95%CI=1.36-1.86)。
- 具有已知CAE的AED与AD风险的OR=1.19(95%CI=1.11-1.27)。
- AED使用与痴呆诊断之间引入2年滞后时间。
临床怎么用
- 对老年患者处方AED时,应评估认知不良反应风险并优先选择无已知CAE的药物。
- 对长期使用AED的老年人,建议监测认知功能变化。
- 在痴呆风险评估中,应将定期AED使用纳入用药史考量。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the association between regular antiepileptic drug (AED) use and incident dementia. DESIGN: Case-control analysis. SETTING: Finnish public health register and German health insurance data. PARTICIPANTS: Individuals with dementia of any type (German data, N=20,325) and Alzheimer's disease (AD; Finnish data, N=70,718) were matched with up to four control persons without dementia. MEASUREMENTS: We analyzed the association between regular AED use and dementia. To address potential protopathic bias, a lag time of 2 years between AED use and dementia diagnosis was introduced. Odds ratios (ORs) were calculated by applying conditional logistic regression, adjusted for potential confounding factors such as comorbidities and polypharmacy. RESULTS: Regular AED use was more frequent in individuals with dementia than controls. Regular use of AEDs was associated with a significantly greater risk of incident dementia (adjusted OR=1.28, 95% confidence interval (CI)=1.14-1.44) and AD (adjusted OR=1.15, 95% CI=1.09-1.22) than no AED use. We also detected a trend toward greater risk of dementia with higher exposure. When AEDs with and without known cognitive adverse effects (CAEs) were compared, a significantly greater risk of dementia was observed for substances with known CAEs (dementia: OR=1.59, 95% CI=1.36-1.86; AD: OR=1.19, 95% CI=1.11-1.27). CONCLUSION: AEDs, especially those with known CAEs, may contribute to incident dementia and AD in older persons.
引用
- Taipale H, Gomm W, Broich K, et al. Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data. J Am Geriatr Soc. 2018. PMID: 29566430. doi:10.1111/jgs.15358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。